Alaunos Therapeutics, Inc. — SC 13G Filings
34 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Alaunos Therapeutics, Inc. (TCRT), sorted by most recent first. Each row links to the full filing on EdgarLookup. Alaunos Therapeutics, Inc. has filed 34 SC 13G documents with the SEC since 2009. To view all SEC filings by Alaunos Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
10SB12G
10SB12G/A
144
3
3/A
4
4/A
424B3
424B5
424B7
424B8
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFC14A
DFAN14A
DFRN14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PRER14A
PRRN14A
REGDEX
S-1
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14F1
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0000834237-22-010175 | Jul 8, 2022 | — |
| SC 13G | — | 0000919574-21-000073 | Jan 7, 2021 | — |
| SC 13G | SCHEDULE 13G | 0001804350-20-000001 | Feb 24, 2020 | — |
| SC 13G | SCHEDULE 13G | 0001104659-20-016345 | Feb 11, 2020 | — |
| SC 13G | MILLER VALUE PARTNERS, LLC | 0001085146-19-000809 | Feb 14, 2019 | — |
| SC 13G | SC 13G | 0001193125-18-335464 | Nov 28, 2018 | — |
| SC 13G | SC 13G | 0001567619-18-006847 | Nov 21, 2018 | — |
| SC 13G | SC 13G | 0001104659-17-034284 | May 22, 2017 | — |
| SC 13G | — | 0000932471-17-001927 | Feb 10, 2017 | — |
| SC 13G | — | 0000215457-17-002745 | Jan 30, 2017 | — |
| SC 13G | SCHEDULE 13G | 0001193125-10-141630 | Jun 17, 2010 | — |
| SC 13G | SCHEDULE 13G | 0001193125-10-141504 | Jun 17, 2010 | — |
| SC 13G | DOC ONE | 0000315066-10-002764 | May 10, 2010 | — |
| SC 13G | — | 0001044321-10-000070 | Feb 12, 2010 | — |
| SC 13G | — | 0000947871-10-000067 | Jan 26, 2010 | — |
| SC 13G | — | 0000930413-09-006196 | Dec 14, 2009 | — |
| SC 13G | SCHEDULE 13G | 0001193125-09-251941 | Dec 14, 2009 | — |
| SC 13G | SCHEDULE 13G | 0001193125-07-052207 | Mar 12, 2007 | — |
| SC 13G | SCHEDULE 13G | 0001193125-07-050598 | Mar 9, 2007 | — |
| SC 13G | SCHEDULE 13G | 0000913849-07-000112 | Mar 5, 2007 | — |
| SC 13G | BENEFICIAL OWNERSHIP OF 5% OR MORE | 0001104659-06-036419 | May 22, 2006 | — |
| SC 13G | SCHEDULE 13G | 0001193125-06-112962 | May 15, 2006 | — |
| SC 13G | SCHEDULE 13G | 0001193125-06-112806 | May 15, 2006 | — |
| SC 13G | SCHEDULE 13G | 0001193125-06-110464 | May 12, 2006 | — |
| SC 13G | SCHEDULE 13G | 0000932440-06-000241 | May 11, 2006 | — |
| SC 13G | SCHEDULE 13G | 0001169232-06-002305 | May 10, 2006 | — |
| SC 13G | SC 13G ZIOPHARM ONCOLOGY, INC. | 0000806085-06-000076 | May 5, 2006 | — |
| SC 13G | — | 0001144204-06-005083 | Feb 10, 2006 | — |
| SC 13G | — | 0000950116-06-000485 | Feb 10, 2006 | — |
| SC 13G | SEPTEMBER 23, 2005 | 0001013594-05-000412 | Sep 23, 2005 | — |
| SC 13G | FORM 13-G | 0001049107-03-000034 | Nov 26, 2003 | — |
| SC 13G | FORM 13-G | 0001049107-03-000033 | Nov 26, 2003 | — |
| SC 13G | FORM 13-G | 0001049107-03-000032 | Nov 26, 2003 | — |
| SC 13G | FORM 13-G | 0001049107-03-000031 | Nov 26, 2003 | — |